Publications by authors named "R Siraneci"
Introduction: Intravenous immunoglobulin (IVIG) is an alternative for post-exposure prophylaxis if a vaccine is contraindicated and intramuscular immunoglobulin is unavailable. We retrospectively examined the effect of IVIG administration time on measles development in measles-contact infants younger than 6 months of age.
Methodology: Contact tracing of measles cases was performed by the Istanbul Public Health Directorate (IPHD) between August 24, 2012, and June 16, 2013.
Article Synopsis
- The study aims to evaluate the effectiveness of complete blood count (CBC) parameters and various ratios in distinguishing pulmonary tuberculosis (TB) from community-acquired pneumonia (CAP) in children.
- It analyzed data from 163 patients and found that certain CBC values and serum electrolyte levels differed significantly between TB and CAP, with CAP showing higher counts for neutrophils, monocytes, and other markers.
- The findings indicate that specific CBC parameters and ratios, along with C-reactive protein (CRP), can serve as useful and cost-effective diagnostic tools for early differentiation between these two infectious diseases.
Evaluation of clinical and laboratory characteristics of childhood tuberculosis.
Turk Pediatri Ars
September 2020
Aim: Tuberculosis is one of the oldest and most contagious diseases of human history. One- quarter of the world's population is infected with the tuberculosis bacillus. Childhood tuberculosis does not have a standard clinical and radiologic description.
View Article and Find Full Text PDFImmediate adverse reactions to intravenous immunoglobulin in children: a single center experience.
Eur Ann Allergy Clin Immunol
January 2017
Intravenous immunoglobulin (IVIG) is commonly used in primary and secondary immunodeficiency diseases as well as autoimmune conditions as immunomodulatator treatment. Immediate adverse events which are generally mild and occur during infusion are seen in 6 hours. Reported immediate adverse events are in a wide range from 1%-40% in pediatric patients.
View Article and Find Full Text PDF